UK-BASED SUPPLIER · ESTABLISHED 2023
Research-grade peptides, verified by third-party analysis.
Supplied to independent researchers, academic laboratories, and accredited institutions. Purity verified by HPLC and mass spectrometry on every batch.
≥98%
HPLC PURITY
2pm
DISPATCH CUT-OFF
-20°C
COLD CHAIN
COA
PER BATCH
Most studied compounds
Latest from the peptide industry
Research Pipeline
MOTS-c: The Mitochondria-Encoded Peptide With a Decade of Preclinical Evidence and a Critical FDA Compounding Vote Eleven Days Away
MOTS-c, a 16-amino acid peptide encoded within mitochondrial DNA, is set for formal FDA advisory review on 23 July 2026 as part of the PCAC's evaluation of seven peptides for the 503A Bulk Drug Substances List. FDA briefing documents propose that it should not be listed, citing insufficient human data and characterisation gaps — yet a Phase 2a trial in prediabetes is now registered, adding new urgency to procurement decisions for UK research labs.
25 Jul 2026
Research Pipeline
KPV: The Alpha-MSH Tripeptide With Two Decades of Preclinical Evidence and an FDA Compounding Vote Nine Days Away
KPV (Lys-Pro-Val) is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone with a substantive body of preclinical evidence in inflammatory bowel disease, wound healing, and dermatology. On 23 July 2026, it faces its first formal FDA scientific review at the Pharmacy Compounding Advisory Committee — and the agency's own briefing documents lean against listing it on the 503A Bulk Drug Substances List.
25 Jul 2026
Research Pipeline
Thymosin Alpha-1: The Thymic Peptide With Four Decades of Clinical Evidence and a Divided Global Regulatory Map
Thymosin alpha-1 (Tα1) occupies a singular position in the peptide landscape: it is approved as a prescription medicine in more than 35 countries under the brand name Zadaxin, yet it holds no FDA approval in the United States and no MHRA marketing authorisation in the UK. This briefing reviews the compound's mechanism, the depth of its clinical evidence base, its evolving US compounding status, and what the regulatory asymmetry means for UK research-procurement professionals.
25 Jul 2026
Every batch, documented.
HPLC purity analysis, mass spectrometry confirmation, and batch traceability — downloadable per product, matched to the batch code on your vial.
View our methodology →
Cold chain maintained.
Lyophilised product held at -20°C in temperature-controlled storage from receipt to dispatch. Stability guaranteed under documented conditions.
Storage protocols →
Same-day, plain packaging.
Orders placed before 2pm dispatched the same working day. Tracked UK delivery, discreet unbranded packaging as standard.
Shipping & returns →